Searched for
DRUG DISCOVERY AND HEALTHCARE
Intel spinout Articul8 eyes $50 million for India heritage AI ventureArticul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
IT still a question mark; 6 sectors where Envision Capital's Nilesh Shah is actually putting moneyNilesh Shah, MD and CEO of Envision Capital, is buying through market volatility but steering clear of IT, questioning the validity of curr...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Amaravati still under construction, but Quantum Valley project already luring deep tech startups, scientistsAmaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...
Anthropic in talks to raise $30 billion at $900 billion valuationAI firm Anthropic is in early talks to raise over thirty billion dollars. The company seeks a valuation exceeding nine hundred billion doll...
DeepMind CEO Demis Hassabis’ Isomorphic Labs raises $2.1 billion led by Thrive CapitalAI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...
Fractal bets big on enterprise AI despite TMT weakness dragging revenue growthAnalytics firm Fractal sees robust enterprise AI growth, with banking and life sciences booming at 40% and 80% respectively. Despite a dip ...
Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
ET Most Innovative AI Product Awards 2026: Honouring the innovations powering India's next economyThe ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...
Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...